United States · FDA National Drug Code directory
Solifenacin Succinate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72205-021_eaccb7fc-2098-43d1-a64e-759b8d4c35c2
- Product NDC
- 72205-021
- Form
- TABLET
- Composition / generic term
- Solifenacin Succinate
- Labeler
- Novadoz Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190520
- Source listing expiry
- 20261231
Source-listed ingredients
- SOLIFENACIN SUCCINATE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (72205-021-30) · 72205-021-30
- 90 TABLET in 1 BOTTLE (72205-021-90) · 72205-021-90
- 1000 TABLET in 1 BOTTLE (72205-021-99) · 72205-021-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →